BioSpace News Archive

Tevogen Bio, a pioneering immunotherapy company, announces that Dr. Neal Flomenberg, MD, Professor and Chairman of the Department of Medical Oncology at Thomas Jefferson University, will present preclinical data of TVGN-489, Tevogen’s investigational allogeneic cytotoxic T cell therapy for COVID-19 at the 2021 Annual Meeting of the American Association of Immunologists (AAI)

FARE, the world’s leading non-governmental organization engaged in food allergy advocacy and the largest private funder of food allergy research, announced the addition of Michael Frazier as Executive Vice President and Chief Business Officer.

(i) Study shows impressive tumor uptake of OncoFAP with unprecedented selectivity against healthy organs - (ii) OncoFAP-based molecules are currently being developed for the imaging and therapy of cancer SIENA, ITALY / ACCESSWIRE / April 12, 2021 / Philogen S.p.A., a listed clinical-stage biotechnology company focused on the development of innovative medicines based on tumor targeting antibodies and small molecule ligands, is pleased to announce a publication describing the development and

Powering Precision Health (PPH), the internationally acclaimed Summit focused on precision health and the latest in biomarker research, today announced that its Founder and Chairman, and CEO of Quanterix Kevin Hrusovsky, will lead a panel on Tuesday, April 13, 2021, at the Precision Medicine Leaders Summit’s (PMLS) virtual conference

Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be reporting financial results for the first quarter 2021 before market open on Tuesday, May 11, 2021. Company management will be webcasting a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time.

STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced the appointment of William D. Humphries to its Board of Directors.

Senior Executive from Abbott Laboratories Latin American EPD Division to Accelerate Procaps Group’s Rollout of Global Growth Initiatives & Strengthen Its Management Team

Align Technology, Inc., a leading global medical device company engaged in the design and manufacture of the Invisalign system, iTero intraoral scanners, and exocad CAD/CAM services for orthodontic and restorative dentistry, announced its support to expand access to vaccinations by U.S. dentists.

John Thero to Retire as President and CEO on August 1, 2021 Board Appoints Karim Mikhail, Current SVP and Head of Commercial for Europe, as Successor

Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Paul Levesque, President and Chief Executive Officer will present at the Bloom Burton & Co. Healthcare Investor Conference on Wednesday, April 21, 2021 at 10:30 a.m. ET.